138 related articles for article (PubMed ID: 29071693)
1. Changing Treatment Paradigms for Brain Metastases From Melanoma-Part 2: When and How to Use the New Systemic Agents.
Venur VA; Funchain P; Kotecha R; Chao ST; Ahluwalia MS
Oncology (Williston Park); 2017 Sep; 31(9):659-67. PubMed ID: 29071693
[TBL] [Abstract][Full Text] [Related]
2. Systemic therapies for melanoma brain metastases: which drug for whom and when?
Ramanujam S; Schadendorf D; Long GV
Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
[TBL] [Abstract][Full Text] [Related]
3. Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment.
Ly D; Bagshaw HP; Anker CJ; Tward JD; Grossmann KF; Jensen RL; Shrieve DC
J Neurosurg; 2015 Aug; 123(2):395-401. PubMed ID: 25768829
[TBL] [Abstract][Full Text] [Related]
4. [Systemic treatment of melanoma brain metastases].
Le Rhun É; Mateus C; Mortier L; Dhermain F; Guillot B; Grob JJ; Lebbe C; Thomas M; Jouary T; Leccia MT; Robert C
Cancer Radiother; 2015 Feb; 19(1):48-54. PubMed ID: 25656856
[TBL] [Abstract][Full Text] [Related]
5. Melanoma brain metastasis: overview of current management and emerging targeted therapies.
Fonkem E; Uhlmann EJ; Floyd SR; Mahadevan A; Kasper E; Eton O; Wong ET
Expert Rev Neurother; 2012 Oct; 12(10):1207-15. PubMed ID: 23082737
[TBL] [Abstract][Full Text] [Related]
6. Management of Brain Metastases in Patients With Melanoma.
Chukwueke U; Batchelor T; Brastianos P
J Oncol Pract; 2016 Jun; 12(6):536-42. PubMed ID: 27288470
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapy for brain metastases.
Venur VA; Karivedu V; Ahluwalia MS
Handb Clin Neurol; 2018; 149():137-153. PubMed ID: 29307351
[TBL] [Abstract][Full Text] [Related]
8. The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases.
Moraes FY; Taunk NK; Marta GN; Suh JH; Yamada Y
Oncologist; 2016 Feb; 21(2):244-51. PubMed ID: 26764249
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint blockade in patients with melanoma metastatic to the brain.
Di Giacomo AM; Margolin K
Semin Oncol; 2015 Jun; 42(3):459-65. PubMed ID: 25965364
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
[TBL] [Abstract][Full Text] [Related]
11. Management of Brain Metastases in the New Era of Checkpoint Inhibition.
Lauko A; Thapa B; Venur VA; Ahluwalia MS
Curr Neurol Neurosci Rep; 2018 Aug; 18(10):70. PubMed ID: 30121715
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
[TBL] [Abstract][Full Text] [Related]
13. Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases.
Patel BG; Ahmed KA; Johnstone PA; Yu HH; Etame AB
Melanoma Res; 2016 Aug; 26(4):382-6. PubMed ID: 26926151
[TBL] [Abstract][Full Text] [Related]
14. [Melanoma brain metastases : Treatment options].
Rauschenberg R; Tabatabai G; Troost EG; Garzarolli M; Beissert S; Meier F
Hautarzt; 2016 Jul; 67(7):536-43. PubMed ID: 27206449
[TBL] [Abstract][Full Text] [Related]
15. Retrospective study of patients with brain metastases from melanoma receiving concurrent whole-brain radiation and temozolomide.
Devito N; Yu M; Chen R; Pan E
Anticancer Res; 2011 Dec; 31(12):4537-43. PubMed ID: 22199328
[TBL] [Abstract][Full Text] [Related]
16. Treatment of brain metastases from melanoma.
McWilliams RR; Brown PD; Buckner JC; Link MJ; Markovic SN
Mayo Clin Proc; 2003 Dec; 78(12):1529-36. PubMed ID: 14661682
[TBL] [Abstract][Full Text] [Related]
17. Systemic therapy of brain metastases.
Brastianos HC; Cahill DP; Brastianos PK
Curr Neurol Neurosci Rep; 2015; 15(2):518. PubMed ID: 25492479
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases.
Eggen AC; Hospers GAP; Bosma I; Kramer MCA; Reyners AKL; Jalving M
BMC Cancer; 2022 Mar; 22(1):247. PubMed ID: 35247992
[TBL] [Abstract][Full Text] [Related]
19. The role of systemic therapies in the management of melanoma brain metastases.
Lyle M; Long GV
Curr Opin Oncol; 2014 Mar; 26(2):222-9. PubMed ID: 24434634
[TBL] [Abstract][Full Text] [Related]
20. Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: an overview of the literature.
Lombardi G; Di Stefano AL; Farina P; Zagonel V; Tabouret E
Cancer Treat Rev; 2014 Sep; 40(8):951-9. PubMed ID: 24909312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
